A new study on tirzepatide, the compound in Mounjaro and Zepbound, gives an early indication.
Tag: Obesity
-
A New Match for Menopausal Weight Gain: Ozempic
Weight gain is one of the most common concerns among women going through menopause. New drugs could change that.
-
Weight Loss Drug Wegovy Can Cut Heart Attack Risk for Some, Study Shows
The results of a large clinical trial suggest the obesity medication could also change the landscape of cardiovascular care.
-
FDA Approves Zepbound, A Drug Like Ozempic, for Weight Loss. Here’s What to Know.
The obesity medication contains tirzepatide, the same active ingredient in the diabetes drug Mounjaro.